McKesson Corp. Hits New 52-Week High at $138.43 (MCK)
McKesson Corp. (NYSE:MCK)’s share price reached a new 52-week high during trading hours on Tuesday, Analyst Ratings Network.com reports. The company traded as high as $138.43 and last traded at $133.79, with a volume of 4,984,304 shares traded. The stock had previously closed at $129.63.
Several analysts have recently commented on the stock. Analysts at Sterne Agee reiterated a “buy” rating on shares of McKesson Corp. in a research note to investors on Tuesday, October 1st. They now have a $164.00 price target on the stock. Separately, analysts at Robert W. Baird raised their price target on shares of McKesson Corp. from $135.00 to $150.00 in a research note to investors on Tuesday, October 1st. They now have an “outperform” rating on the stock. Finally, analysts at UBS AG raised their price target on shares of McKesson Corp. from $127.00 to $143.00 in a research note to investors on Wednesday, September 25th. They now have a “buy” rating on the stock. Two investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $132.25.
McKesson Corp. has a one year low of $88.45 and a one year high of $133.33. The stock has a 50-day moving average of $126. and a 200-day moving average of $117.2. The company has a market cap of $30.522 billion and a price-to-earnings ratio of 22.27.
McKesson Corp. (NYSE:MCK) last issued its quarterly earnings data on Thursday, July 25th. The company reported $2.07 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.71 by $0.36. The company had revenue of $32.20 billion for the quarter, compared to the consensus estimate of $32.60 billion. During the same quarter last year, the company posted $1.55 earnings per share. McKesson Corp.’s revenue was up 4.9% compared to the same quarter last year.
McKesson Corporation delivers pharmaceuticals, medical supplies and healthcare information technologies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.